Publication | Closed Access

Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience

Translational MedicineUrologyTransplantationKidney TransplantKidney ResearchKidney TransplantationImmunologySingle-center ExperienceGraft RejectionMedicineLiving-related Renal TransplantationNephrologyInduction Therapy